OMA Guidelines Bundle

Obesity Nutrition and Activity 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544299

Contents of this Issue

Navigation

Page 14 of 33

15 Low-Calorie Dietary Patterns Typically 1000–1200 kcal/d for women and 1200–1600 kcal/d for men. Considerations Weight Loss • Consists of conventional foods and 1–4 meal replacements per day • Structure is a moderate-fat, higher- protein diet with reduced ref ined carbohydrates, with a f ixed energy allowance • Can be used for more extended periods of time as compared to very-low-calorie diets • Lower rate than the VLEDs • Randomized controlled trials demonstrate that the long- term (>1 year) weight loss is not different f rom the VLEDs Risks • Similar, but with a lower degree of risk than the VLEDs • May be benef icial for introducing healthy eating habits, familiarizing with dietary changes, and encouraging long-term weight maintenance • Risk of malnutrition, and therefore needs guidance f rom a dietician Carbohydrate-Restricted Dietary Patterns Low carbohydrate: <130 grams of carbohydrate/d or <26% calories/d. Very low carbohydrate (ketogenic): <50 grams of carbohydrate/d (see Low-Calorie and Very-Low-Calorie Diets f igure) Weight Loss Metabolic Effects • May produce greater weight loss compared to a fat-restricted dietary intake for the f irst six months • After six months, net weight loss may be similar to other calorie- restricted nutritional interventions • Lower rate than the VLEDs • Randomized controlled trials demonstrate that the long- term (>1 year) weight loss is not different f rom the VLEDs Risks • May produce carbohydrate cravings within the f irst few days of implementation, which may be mitigated by adding low-glycemic-index carbohydrate foods • May induce a gout flare in patients with a history of gout • May result in malaise • May pose challenges in patients with restrictions on dietary protein due to severe kidney disease • Monitor patients receiving treatment for diabetes mellitus and hypertension for signs of hypoglycemia and hypotension; adjust medications as necessary

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Nutrition and Activity 2026